A metastatic malignancy of unknown primary origin in a 12-year-old girl with anti-N-methyl-d-aspartate encephalitis.

07:00 EST 13th February 2020 | BioPortfolio

Summary of "A metastatic malignancy of unknown primary origin in a 12-year-old girl with anti-N-methyl-d-aspartate encephalitis."

No Summary Available


Journal Details

This article was published in the following journal.

Name: Pediatrics international : official journal of the Japan Pediatric Society
ISSN: 1442-200X


DeepDyve research library

PubMed Articles [18998 Associated PubMed Articles listed on BioPortfolio]

The scheme of diagnosis and treatment on metastatic cervical carcinomas from an unknown primary.

Metastatic cervical carcinomas from unknown primary(MCCUP) are a group of metastatic carcinomas of cervical lymph nodes which could not be managed to find their origins. The diagnosis of MCCUP inc...

Fine needle aspiration of the liver: a ten-year single institution retrospective review.

Fine-needle aspiration (FNA) of liver masses is a minimally invasive means of evaluation, with diagnostic accuracy over 85%. Given that most of the recent literature on sampling hepatic tumors was pub...

Interventions for chronic pruritus of unknown origin.

Pruritus is a sensation that leads to the desire to scratch; its origin is unknown in 8% to 15% of affected patients. The prevalence of chronic pruritus of unknown origin (CPUO) in individuals with ge...

Primary Alveolar Rhabdomyosarcoma of the Breast in a 17-Year-Old Girl.

CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.

Twenty-six Krukenberg tumors (16 lower gastrointestinal, 4 upper gastrointestinal, and 6 of unknown origin) and their primaries when known were stained with CDX2, SATB2, GATA3, TTF1, and PAX8 using a ...

Clinical Trials [13013 Associated Clinical Trials listed on BioPortfolio]

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not ye...

Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary

This study is designed to evaluate the value of tissue-of-origin (ORIGIN-PanCA○R) profiling in predicting primary site and directing therapy in patients with cancer of unknown primary.

Evaluation of Diagnosis of Fever and Biologic Inflammatory Syndrome of Unknown Origin

Fever of unknown origin (FUO) and biologic inflammatory syndrome of unknown origin (SII) are two frequent causes of hospitalization or consultation in infectious disease unit and internal ...

Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies

The pathworks tissue of origin test is a microarray-based test with the goal of identifying the tissue of origin in patients with metastatic tumors of unknown primary site.

Girl Empower: Studying the Impact of Mentorship, Asset Building, Caregiver Discussion Groups, and Cash Transfers on Reducing Girl's Vulnerability to Sexual Exploitation and Abuse

Girl Empower (GE) is a program designed to equip girls with the skills and experiences necessary to make healthy, strategic life choices and to stay safe from sexual exploitation and abuse...

Medical and Biotech [MESH] Definitions

Metastases in which the tissue of origin is unknown.

Mucocellular carcinoma of the ovary, usually metastatic from the gastrointestinal tract, characterized by areas of mucoid degeneration and the presence of signet-ring-like cells. It accounts for 30%-40% of metastatic cancers to the ovaries and possibly 1%-2% of all malignant ovarian tumors. The lesions may not be discovered until the primary disease is advanced, and most patients die of their disease within a year. In some cases, a primary tumor is not found. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1685)

A rare, benign, inflammatory breast disease occurring in premenopausal women shortly after a recent pregnancy. The origin is unknown but it is commonly mistaken for malignancy and sometimes associated with BREAST FEEDING and the use of ORAL CONTRACEPTIVES.

Primary and metastatic (secondary) tumors of the brain located above the tentorium cerebelli, a fold of dura mater separating the CEREBELLUM and BRAIN STEM from the cerebral hemispheres and DIENCEPHALON (i.e., THALAMUS and HYPOTHALAMUS and related structures). In adults, primary neoplasms tend to arise in the supratentorial compartment, whereas in children they occur more frequently in the infratentorial space. Clinical manifestations vary with the location of the lesion, but SEIZURES; APHASIA; HEMIANOPSIA; hemiparesis; and sensory deficits are relatively common features. Metastatic supratentorial neoplasms are frequently multiple at the time of presentation.

A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).

Quick Search

DeepDyve research library

Searches Linking to this Article